MedTrace Logo

Docosahexaenoic Acid Serum Levels in Patients With Preeclampsia

NCT05591638 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2022-10-24

No results posted yet for this study

Summary

By comparing the blood levels of docosahexaenoic acid (DHA) in preeclamptic patients with normal pregnant women, we aim to reveal the relationship between these markers, which are known to be effective on metabolic function, and preeclampsia, and to contribute to future studies and possible treatment options

Conditions

Sponsors & Collaborators

  • Recep Tayyip Erdogan University Training and Research Hospital

    lead OTHER

Principal Investigators

  • SENOL SENTURK · Recep Tayyip Erdogan University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-24
Primary Completion
2023-04-30
Completion
2023-05-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05591638 on ClinicalTrials.gov